Integer Holdings (ITGR) Non-Current Deferred Tax Liability (2010 - 2026)
Integer Holdings (ITGR) reported Non-Current Deferred Tax Liability of $115.1 million for Q2 2026, up 3.51% on a YoY basis from $111.2 million in Q2 2025, and down 1.06% sequentially from $116.3 million in Q4 2025.
Integer Holdings (ITGR) Non-Current Deferred Tax Liability (2010 - 2026) Analysis & Trends
Integer Holdings (ITGR) has 17 years of Non-Current Deferred Tax Liability data on file, last reported at $115.1 million in Q2 2026.
- For the quarter ending Q2 2026, Non-Current Deferred Tax Liability rose 3.51% year-over-year to $115.1 million; the trailing twelve-month figure through Apr 2026 stood at $115.1 million (up 3.51% YoY), and the FY2025 full-year result was $116.3 million, down 43.69% from the prior year.
- Non-Current Deferred Tax Liability declined to $115.1 million in Q2 2026, from $116.3 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $206.6 million in Q4 2024 to a low of $111.2 million in Q1 2025.
- A 5-year average of $147.0 million and a median of $145.2 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
- Across the five-year window, Non-Current Deferred Tax Liability jumped 43.92% in 2024 and slumped 43.69% in 2025, its largest moves.
- Tracing ITGR's Non-Current Deferred Tax Liability over 5 years: stood at $160.7 million in 2022, then retreated by 10.65% to $143.6 million in 2023, then jumped by 43.92% to $206.6 million in 2024, then tumbled by 43.69% to $116.3 million in 2025, then dropped by 1.06% to $115.1 million in 2026.
- Business Quant data shows ITGR's Non-Current Deferred Tax Liability at $115.1 million in Q2 2026, $116.3 million in Q4 2025, and $114.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Integer Holdings | 3.34 Bn | 3.33 Bn | 109.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | 115.10 Mn |
| Apr 3, 2026 | 115.10 Mn |
| Dec 31, 2025 | 116.33 Mn |
| Dec 31, 2025 | 116.33 Mn |
| Sep 26, 2025 | 114.70 Mn |
| Sep 26, 2025 | 114.70 Mn |
| Jun 27, 2025 | 114.74 Mn |
| Jun 27, 2025 | 114.74 Mn |
| Mar 28, 2025 | 111.20 Mn |
| Mar 28, 2025 | 111.20 Mn |
| Dec 31, 2024 | 206.60 Mn |
| Dec 31, 2024 | 206.60 Mn |
| Sep 27, 2024 | 143.24 Mn |
| Sep 27, 2024 | 143.24 Mn |
| Jun 28, 2024 | 144.10 Mn |
| Jun 28, 2024 | 144.10 Mn |
| Mar 29, 2024 | 145.20 Mn |
| Mar 29, 2024 | 145.20 Mn |
| Dec 31, 2023 | 143.55 Mn |
| Dec 31, 2023 | 143.55 Mn |